A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This clinical trial is a prospective, randomized, controlled and multicenter study.And the
trial is going to enroll better control intrahepatic tumors for hepatocellular carcinoma(HCC)
patients who meet the inclusion criterion.The patients were divided into two groups, the
group A by TACE and the other group B by external- beam radiotherapy(EBRT) after 2 times
TACE. Then the therapeutic effects and toxicities of TACE and EBRT are evaluated during the
follow-up period. The study design plans to enroll 300 patients, and each group includes 150
cases.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborators:
309th Hospital of Chinese People's Liberation Army affiliated Zhongshan hospital of Dalian university Anhui Provincial Hospital Beijing Cancer Hospital Changhai Hospital First Affiliated Hospital of Fujian Medical University First Affiliated Hospital of Guangxi Medical University First Affiliated Hospital of Xinjiang Medical University First Affiliated Hospital of Zhejiang University Fudan University Fujian Cancer Hospital Heilongjiang Provincial Agricultural Reclamation General Hospital Jilin University Longyan First Hospital, Affiliated to Fujian Medical University Peking University First Hospital Qingdao University Shanghai 10th People's Hospital Subei People's Hospital of Jiangsu Province,Yangzhou University The 4th people's hospital of Wuxi City,Affiliated to Jiangnan Universit The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School The First Affiliated Hospital of Xiamen University The Third Affiliated Hospital of Qiqihar Medical Vniversitiy West China Hospital Xinqiao Hospital of Chongqing Zhongshan Hospital Xiamen University